Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Accounts Payables (2013 - 2026)

Scynexis' (SCYX) quarterly Accounts Payables came in at $3.3 million in Q2 2026, down 47.1% on a YoY basis from $6.2 million in Q2 2025, and down 42.03% quarter-over-quarter from $5.6 million in Q1 2026.

Analysis

Scynexis (SCYX) Accounts Payables (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Accounts Payables for 14 consecutive years, with $3.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accounts Payables fell 47.1% year-over-year to $3.3 million; the trailing twelve-month figure through Jun 2026 stood at $3.3 million (down 47.1% YoY), and the FY2025 full-year result was $2.2 million, down 51.3% from the prior year.
  • Accounts Payables retreated to $3.3 million in Q2 2026 per SCYX's latest filing, from $5.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $10.0 million in Q2 2022 and bottomed at $2.2 million in Q4 2025.
  • Historically, Accounts Payables has averaged $5.6 million across 5 years, with a median of $5.5 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Accounts Payables jumped 67.51% in 2022, then tumbled 65.7% in 2023.
  • Over 5 years, Accounts Payables stood at $5.9 million in 2022, then gained by 20.41% to $7.1 million in 2023, then plunged by 36.09% to $4.6 million in 2024, then plunged by 51.3% to $2.2 million in 2025, then jumped by 46.74% to $3.3 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $3.3 million, $5.6 million, and $2.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.52 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 25.08 Mn
10 Scynexis 58.41 Mn -56.29 Mn - 3.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.27 Mn
Mar 31, 2026 5.63 Mn
Dec 31, 2025 2.23 Mn
Sep 30, 2025 3.47 Mn
Jun 30, 2025 6.17 Mn
Mar 31, 2025 4.26 Mn
Dec 31, 2024 4.57 Mn
Sep 30, 2024 4.96 Mn
Jun 30, 2024 5.35 Mn
Mar 31, 2024 8.92 Mn
Dec 31, 2023 7.15 Mn
Sep 30, 2023 3.49 Mn
Jun 30, 2023 3.42 Mn
Mar 31, 2023 5.93 Mn
Dec 31, 2022 5.94 Mn
Sep 30, 2022 7.42 Mn
Jun 30, 2022 9.96 Mn
Mar 31, 2022 8.13 Mn
Dec 31, 2021 7.85 Mn
Sep 30, 2021 7.51 Mn